BAT Announces Repurchase of 74,186 Shares as Part of Ongoing Buyback Program

Nov.28.2024
BAT Announces Repurchase of 74,186 Shares as Part of Ongoing Buyback Program
BAT has repurchased 74,186 shares from Merrill Lynch International, reducing its share count to 2.21 billion, enhancing shareholder value through potential EPS growth.

British American Tobacco PLC (BAT) has repurchased 74,186 ordinary shares at an average price of 2,999.38 pence per share from Merrill Lynch International. This repurchase forms part of the Company's ongoing buyback program, as announced on 28 November.

 

The transaction, initially announced on 18 March 2024 and authorized by shareholders at the Company's Annual General Meeting on 24 April 2024, was completed on 27 November 2024.

 

Key details of the transaction are as follows:

 

  • Date of purchase: 27 November 2024

 

  • Number of shares repurchased: 74,186

 

  • Highest price paid per share: 3,010.00 pence

 

  • Lowest price paid per share: 2,978.00 pence

 

  • Volume weighted average price paid per share: 2,999.38 pence

 

After the purchase and cancellation, BAT's total number of ordinary shares in issue (excluding treasury shares) will be 2,210,937,032.

 

This reduction in shares is part of a strategic decision designed to enhance shareholder value by potentially increasing earnings per share.

 

Additionally, shareholders may need to assess whether they are required to notify any changes to their interest in the company, in accordance with the FCA's Disclosure Guidance and Transparency Rules.

 

Former Malaysian Health Minister Allegedly Rejected RM50 Million Bribe Over GEG
Former Malaysian Health Minister Allegedly Rejected RM50 Million Bribe Over GEG
A former political aide has alleged that a RM50 million bribe was offered to Malaysia’s then health minister to abandon the tobacco generational end game (GEG) policy. The claim was published in an opinion article and on social media. No report was made to anti-corruption authorities. Despite the alleged rejection, the GEG provision was later removed from the tobacco bill tabled in Parliament in 2023.
Dec.23 by 2FIRSTS.ai
Belgium Plans to Ban All Vape Flavours Except Tobacco, Backed by Health Council
Belgium Plans to Ban All Vape Flavours Except Tobacco, Backed by Health Council
Belgian Health Minister Frank Vandenbroucke has announced plans to ban all e-cigarette flavours except tobacco, following new advice from the Superior Health Council (CSS). The move marks a major policy shift, as the Council now fully supports flavour restrictions to curb youth vaping.
Nov.19 by 2FIRSTS.ai
Breaking News | China’s Premier Li Qiang Issues Rare Directive to Crack Down on Illicit Tobacco Activities
Breaking News | China’s Premier Li Qiang Issues Rare Directive to Crack Down on Illicit Tobacco Activities
Based on combined reporting from Xinhua and Xinwen Lianbo, 2Firsts reports that Chinese Premier Li Qiang has issued a rare directive at a State Council executive meeting to launch comprehensive, full-chain enforcement against illicit tobacco activities.
News
Dec.05
China Announces Crackdown on Illegal Nicotine Pouch Manufacturing Involving Counterfeit VELO, ZYN, and PABLO Products
China Announces Crackdown on Illegal Nicotine Pouch Manufacturing Involving Counterfeit VELO, ZYN, and PABLO Products
The case is valued at approximately 400,000 yuan, and two suspects have been taken into custody.Video footage released by authorities shows that the counterfeit products involved well-known market brands such as VELO, ZYN, and PABLO.
Dec.01
Denmark Proposes Sharper Tax Hike: Heated Tobacco Up 132%, Nicotine Pouches Facing 1,000% Increase
Denmark Proposes Sharper Tax Hike: Heated Tobacco Up 132%, Nicotine Pouches Facing 1,000% Increase
According to foreign media, the European Union will examine a strengthened Danish proposal to amend the Tobacco Excise Directive. The plan introduces sharper tax increases on heated tobacco, nicotine pouches and other products. Despite overwhelming public opposition in earlier consultations, the revision continues to move forward, raising concerns about supply chain impacts and potential growth in illicit trade.
Dec.04
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.
Dec.02 by 2FIRSTS.ai